A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation

FLT3-ITD-mutated acute myeloid leukemia (AML) remains a therapeutic challenge. FLT3 inhibition in the setting of minimal residual disease and a new immune system via allogeneic transplantation offers a promise of improved survival for these patients. We performed a prospective study of patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Pratz, Keith W., Rudek, Michelle A., Smith, B. Douglas, Karp, Judith, Gojo, Ivana, Dezern, Amy, Jones, Richard J., Greer, Jackie, Gocke, Christopher, Baer, Maria R., Duong, Vu H., Rosner, Gary, Zahurak, Marianna, Wright, John J., Emadi, Ashkan, Levis, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001148/
https://ncbi.nlm.nih.gov/pubmed/31550496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.09.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados